Madrigal Pharmaceuticals (MDGL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 24.71% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.77% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -99.85% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.70% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -79.16% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 10.87% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19.14% |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 617.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 617.77% |
| Mar 31, 2026 | 322.67% |
| Dec 31, 2025 | -31.55% |
| Sep 30, 2025 | 28.44% |
| Jun 30, 2025 | -4.72% |
| Mar 31, 2025 | 9.13% |
| Dec 31, 2024 | 41.02% |
| Sep 30, 2024 | 244.16% |
| Jun 30, 2024 | 272.53% |
| Mar 31, 2024 | 240.23% |
| Dec 31, 2023 | 158.40% |
| Sep 30, 2023 | -5.99% |
| Jun 30, 2023 | -42.33% |
| Mar 31, 2023 | -35.68% |
| Dec 31, 2022 | -29.38% |
| Sep 30, 2022 | -16.94% |
| Jun 30, 2022 | -11.45% |
| Mar 31, 2022 | -18.61% |
| Dec 31, 2021 | -18.72% |
| Sep 30, 2021 | -26.80% |